| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |